EPIRUS Biopharmaceuticals Inc EPRSQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $26.18
- Volume/Avg
- 191 / 11,461
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
EPIRUS Biopharmaceuticals Inc is a global biopharmaceutical company focused on building biosimilar business targeting rare diseases by improving patient access through cost-effective medicines. The product candidates of the company are BOW080 for the potential treatment of ultra-rare blood disorders and BOW070 for the potential treatment of an uncommon lymphoproliferative disorder known as Castleman’s disease. The group generally operates through the United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 73
- Website
- http://www.epirusbiopharma.com
Valuation
|
Metric
|
EPRSQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EPRSQ
|
|---|---|
Quick Ratio | 0.64 |
Current Ratio | 0.79 |
Interest Coverage | −42.19 |
Quick Ratio
EPRSQ
Profitability
|
Metric
|
EPRSQ
|
|---|---|
Return on Assets (Normalized) | −71.15% |
Return on Equity (Normalized) | −115.61% |
Return on Invested Capital (Normalized) | −88.71% |
Return on Assets
EPRSQ
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Nbq | $458.6 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Btkqbl | $90.5 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Fmrcwm | $88.8 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Gtgtnj | $40.1 Bil | |
MRNA
| Moderna Inc | Vtbq | $30.4 Bil | |
ARGX
| argenx SE ADR | Mhzm | $27.0 Bil | |
BNTX
| BioNTech SE ADR | Mky | $23.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Tkywmz | $21.5 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Kmtpt | $17.4 Bil | |
INCY
| Incyte Corp | Cjhwtw | $12.1 Bil |